In several tumors including lung cancer, CD133 has been considered as a molecular marker to identify the CSCs, and the CD133 positive lung cancer cells are reported to exhibit the stem-like probabilities of tumorigenicity, proliferation, and self-renewal [7–9]. This evidence concerns the gene PROM1 and lung carcinoma.